178 related articles for article (PubMed ID: 11192758)
21. Soluble HLA class I and class II molecules in relapsing-remitting multiple sclerosis: acute response to interferon-beta1a treatment and their use as markers of disease activity.
Minagar A; Adamashvilli I; Jaffe SL; Glabus MF; Gonzalez-Toledo E; Kelley RE
Ann N Y Acad Sci; 2005 Jun; 1051():111-20. PubMed ID: 16126950
[TBL] [Abstract][Full Text] [Related]
22. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
[TBL] [Abstract][Full Text] [Related]
23. Embryonic soluble HLA-G as a marker of developmental potential in embryos.
Noci I; Fuzzi B; Rizzo R; Melchiorri L; Criscuoli L; Dabizzi S; Biagiotti R; Pellegrini S; Menicucci A; Baricordi OR
Hum Reprod; 2005 Jan; 20(1):138-46. PubMed ID: 15498780
[TBL] [Abstract][Full Text] [Related]
24. The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation.
Russell CA; Heilmann C; Madsen HO; Vindeløv LL
Bone Marrow Transplant; 2001 May; 27(9):949-58. PubMed ID: 11436105
[TBL] [Abstract][Full Text] [Related]
25. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
26. Skin explant model of human graft-versus-host disease: prediction of clinical outcome and correlation with biological risk factors.
Wang XN; Collin M; Sviland L; Marshall S; Jackson G; Schulz U; Holler E; Karrer S; Greinix H; Elahi F; Hromadnikova I; Dickinson AM
Biol Blood Marrow Transplant; 2006 Feb; 12(2):152-9. PubMed ID: 16443513
[TBL] [Abstract][Full Text] [Related]
27. Soluble HLA in saliva of patients with autoimmune rheumatic diseases.
Adamashvili I; Pressly T; Gebel H; Milford E; Wolf R; Mancini M; Sittg K; Ghali GE; Hall V; McDonald JC
Rheumatol Int; 2002 Jun; 22(2):71-6. PubMed ID: 12070679
[TBL] [Abstract][Full Text] [Related]
28. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
29. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
Morandi F; Levreri I; Bocca P; Galleni B; Raffaghello L; Ferrone S; Prigione I; Pistoia V
Cancer Res; 2007 Jul; 67(13):6433-41. PubMed ID: 17616704
[TBL] [Abstract][Full Text] [Related]
30. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM
Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502
[TBL] [Abstract][Full Text] [Related]
31. [Significance and features of MLC reaction in histocompatibility determination of donor and recipient in allogenic bone marrow transplantation to patients with hematological malignancies].
Shpakova AP; Bulycheva TI; Liubimova LS; Mendeleeva LP
Ter Arkh; 2000; 72(11):62-7. PubMed ID: 11229316
[TBL] [Abstract][Full Text] [Related]
32. [A trial of using allogeneic bone marrow transplantation in children with different hematologic neoplastic diseases].
Zubarovskaia LS; Sitskaia KO; Marinets OV; Fregatova LM; Belogurova MB; Trofimova SA; Chukhlovin AB; Afanas'ev BV
Ter Arkh; 1998; 70(7):60-3. PubMed ID: 9742640
[TBL] [Abstract][Full Text] [Related]
33. Prediction by a modified mixed leukocyte reaction assay of graft-versus-host disease and graft rejection after allogeneic bone marrow transplantation.
Bishara A; Brautbar C; Nagler A; Slavin S; Leshem B; Cohen I; Kedar E
Transplantation; 1994 May; 57(10):1474-9. PubMed ID: 8197610
[TBL] [Abstract][Full Text] [Related]
34. Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
Ciprandi G; Contini P; Pistorio A; Murdaca G; Puppo F
Int Immunopharmacol; 2009 Feb; 9(2):253-7. PubMed ID: 19100344
[TBL] [Abstract][Full Text] [Related]
35. Plasma soluble human leukocyte antigen G levels in asthmatic children.
Tahan F; Patiroglu T
Int Arch Allergy Immunol; 2006; 141(3):213-6. PubMed ID: 16926540
[TBL] [Abstract][Full Text] [Related]
36. Soluble HLA-G in rheumatoid arthritis.
Verbruggen LA; Rebmann V; Demanet C; De Cock S; Grosse-Wilde H
Hum Immunol; 2006 Aug; 67(8):561-7. PubMed ID: 16916651
[TBL] [Abstract][Full Text] [Related]
37. Effects of non-major histocompatibility antigens on acute graft-versus-host reaction after allogeneic bone marrow transplantation.
Takayanagi T; Nishihori H; Matsuki N; Iwabuchi K; Ogasawara K; Onoé K
Bone Marrow Transplant; 1997 Aug; 20(4):297-304. PubMed ID: 9285544
[TBL] [Abstract][Full Text] [Related]
38. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
39. Soluble HLA class I molecules exert differentiated influence on renal graft condition.
Chudyk A; Masiuk M; Myślak M; Domański L; Sieńko J; Sulikowski T; Machaliński B; Giedrys-Kalemba S
Transplant Proc; 2006; 38(1):90-3. PubMed ID: 16504672
[TBL] [Abstract][Full Text] [Related]
40. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ
Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
